Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hematopoietic transcription factor GFI1 promotes anchorage independence by sustaining ERK activity in cancer cells
Hao Wang, Zhenzhen Lin, Zhe Nian, Wei Zhang, Wenxu Liu, Fei Yan, Zengtuan Xiao, Xia Wang, Zhenfa Zhang, Zhenyi Ma, Zhe Liu
Hao Wang, Zhenzhen Lin, Zhe Nian, Wei Zhang, Wenxu Liu, Fei Yan, Zengtuan Xiao, Xia Wang, Zhenfa Zhang, Zhenyi Ma, Zhe Liu
View: Text | PDF
Research Article Cell biology Oncology

Hematopoietic transcription factor GFI1 promotes anchorage independence by sustaining ERK activity in cancer cells

  • Text
  • PDF
Abstract

The switch from anchorage-dependent to anchorage-independent growth is essential for epithelial metastasis. The underlying mechanism, however, is not fully understood. In this study, we identified growth factor independent-1 (GFI1), a transcription factor that drives the transition from adherent endothelial cells to suspended hematopoietic cells during hematopoiesis, as a critical regulator of anchorage independence in lung cancer cells. GFI1 elevated the numbers of circulating and lung-infiltrating tumor cells in xenograft models and predicted poor prognosis of patients with lung cancer. Mechanistically, GFI1 inhibited the expression of multiple adhesion molecules and facilitated substrate detachment. Concomitantly, GFI1 reconfigured the chromatin structure of the RASGRP2 gene and increased its expression, causing Rap1 activation and subsequent sustained ERK activation upon detachment, and this led to ERK signaling dependency in tumor cells. Our studies unveiled a mechanism by which carcinoma cells hijacked a hematopoietic factor to gain anchorage independence and suggested that the intervention of ERK signaling may suppress metastasis and improve the therapeutic outcome of patients with GFI1-positive lung cancer.

Authors

Hao Wang, Zhenzhen Lin, Zhe Nian, Wei Zhang, Wenxu Liu, Fei Yan, Zengtuan Xiao, Xia Wang, Zhenfa Zhang, Zhenyi Ma, Zhe Liu

×

Figure 7

GFI1 establishes the interaction between the enhancer and promoter of RASGRP2.

Options: View larger image (or click on image) Download as PowerPoint
GFI1 establishes the interaction between the enhancer and promoter of RA...
(A) Alignment of human, chimpanzee, Rhesus monkey, and mouse RASGRP2 genes revealed a 50 bp conserved sequence residing within the noncoding region 4 kb upstream from the RASGRP2 transcriptional start site. (B) ChIP shows distribution of H3K4me3 and H3K27ac histone modifications in H1155, H526, A549, and H460 cells. The location of primers is shown in A. (C) Bar graphs show luciferase reporter activity with ectopic placement of the 50 bp conserved DNA sequence (red line in upper diagram) adjacent to the promoter, ectopic placement of mutant GFI1 lacking DNA-binding activity, or mutation of GFI1 binding motif within the enhancer region. Luciferase activity was normalized to Renilla signals. Mean ± SD represents 3 replicates in 1 experiment. Three independent experiments were performed. ****P < 0.0001 (1-way ANOVA test with post hoc contrasts by Tukey’s test). (D) ChIP-Seq showing enrichment of GFI1 in the RASGRP2 locus (top). ChIP-QPCR analysis showing the association of GFI1-Flag in transfected A549 cells with regions 3 and regions 8–10 at the (bottom). The location of primers is shown (middle). (E) 3C was used to calculate the cross-linking frequency between chromatin segments to assess the proximity in A549, H1155, GFI1-expressing A549, and GFI1-deleted H1155 cells. Vertical lines represent Dpn II restriction sites; arrows indicate PCR primer sites and direction. Anchor symbols mark the anchoring primer. Heatmaps showing the cross-linking frequency between the RASGRP2 promoter and other Dpn II–defined segments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts